Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ELEV Elevation Oncology Inc

3,36

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:00:16

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Elevation Oncology (NASDAQ:ELEV)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Elevation Oncology Charts.

Elevation Oncology (NASDAQ:ELEV)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Elevation Oncology Charts.

News Elevation Oncology Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 10 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 9 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
Dienstag 7 Mai 2024 (1 Monat vor) • PR Newswire (US)

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
Donnerstag 2 Mai 2024 (1 Monat vor) • PR Newswire (US)

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Montag 8 April 2024 (2 Monate vor) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Mittwoch 6 März 2024 (3 Monate vor) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
Dienstag 5 März 2024 (3 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Elevation Oncology Inc News-Artikel

DIFF27F30 - 01/2027

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen